Voriconazole is a triazole antifungal agent used to treat serious invasive fungal infections, including aspergillosis, candidiasis, and other infections caused by pathogens such as Scedosporium and Fusarium.… Read more


![Chemical structure of (2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ((1R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F188416-34-4-2R3S-2-24-Difluorophenyl-3-5-fluoropyrimidin-4-yl-1-1H-124-triazol-1-ylbutan-2-ol-1R-77-dimethyl-2-oxobicyclo2.2.1heptan-1-ylmethanesulfon.png&w=3840&q=75)















Voriconazole is a triazole antifungal agent used to treat serious invasive fungal infections, including aspergillosis, candidiasis, and other infections caused by pathogens such as Scedosporium and Fusarium. This category features a comprehensive range of Voriconazole reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for critical analytical procedures, including impurity profiling, method validation, and routine quality control. By employing these standards, researchers can perform accurate impurity identification, assess drug stability, and support regulatory compliance during forced degradation studies and the development of analytical testing methods. The inclusion of stable isotope labelled standards further enables precise quantification during complex bioanalytical and stability assessments, ensuring the safety and efficacy of the final medicinal product.